Research and Markets (http://www.researchandmarkets.com/research/j35z9p/mild_cognitive)
has announced the addition of the "Mild
Cognitive Impairment Global Clinical Trials Review, H1, 2014"
report to their offering.
Our clinical trial report, Mild Cognitive Impairment Global Clinical
Trials Review, H1, 2014" provides data on the Mild Cognitive Impairment
clinical trial scenario. This report provides elemental information and
data relating to the clinical trials on Mild Cognitive Impairment.
It includes an overview of the trial numbers and their recruitment
status as per the site of trial conduction across the globe. The
databook offers a preiminary coverage of disease clinical trials by
their phase, trial status, prominence of the sponsors and also provides
briefing pertaining to the number of trials for the key drugs for
treating Mild Cognitive Impairment.
This report is built using data and information sourced from proprietary
databases, primary and secondary research and in-house analysis by Our
team of industry experts.
Note: Certain sections in the report may be removed or altered based on
the availability and relevance of data for the indicated disease.
Reasons to buy
For more information visit http://www.researchandmarkets.com/research/j35z9p/mild_cognitive
[ Back To NFVZone's Homepage ]